Immunotherapy drug combination stimulates immune system against resistant cancers 22 Aug 2022 A combination treatment of immunotherapy with the experimental drug guadecitabine may reverse a cancer’s resistance to immunotherapy – making it sensitive to treatment again, a new study has found. Find out more Show/Hide
AI study 'exciting first step' towards improving post-treatment surveillance of lung cancer patients 23 Apr 2022 Artificial intelligence (AI) could help guide the post-treatment surveillance of non-small cell lung cancer (NSCLC) patients and improve outcomes as a result, according to new research. Find out more Show/Hide
AACR 2022: New 'killer' immunotherapy shows early promise in range of solid tumours 08 Apr 2022 A new type of immunotherapy making use of the immune system’s ‘natural killer cells’ could offer potential against a range of cancers that can evade current treatments, early results from a phase I trial suggest. Find out more Show/Hide
New drug for difficult-to-drug cancer mutation could be key treatment for a range of cancers 29 Oct 2020
AACR Virtual Annual Meeting 2020: Personalised cancer vaccine shows promise in early trial 22 Jun 2020